ClearPoint Neuro (CLPT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ClearPoint Neuro (CLPT) last issued guidance on August 3, 2026 for fiscal year 2026. The company guided revenue in the range of $48.00M - $52.00M for the period.
Compared to prior guidance, ClearPoint Neuro lowered its revenue forecast from a prior range of $52.00M - $56.00M.
ClearPoint Neuro has issued 26 guidance updates between August 9, 2022 and August 3, 2026. During this period, the company raised its outlook 5 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.27 | $-0.21 | $-0.20 |
| Actual | $-0.38 | $-0.32 | $-0.23 | $-0.21 |
| Surprise | -35.7% | -18.5% | -9.52% | -5.00% |
| Revenue | ||||
| Estimate | $12.8M | $12.0M | $9.9M | $9.7M |
| Actual | $10.9M | $12.1M | $10.4M | $8.9M |
| Surprise | -14.9% | +0.87% | +4.94% | -8.84% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.26 | $-0.22 | $-0.24 |
| Revenue | |||
| Consensus | $13.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $-0.38 | $-0.28 | -35.7 % |
| Q1 | May 13, 2026 | $-0.32 | $-0.27 | -18.5 % |
| Q4 | Mar 17, 2026 | $-0.23 | $-0.21 | -9.52 % |
| Q3 | Nov 6, 2025 | $-0.21 | $-0.20 | -5.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $10.88M | $12.79M | -14.9 % |
| Q1 | May 13, 2026 | $12.13M | $12.02M | 0.87 % |
| Q4 | Mar 17, 2026 | $10.40M | $9.91M | 4.94 % |
| Q3 | Nov 6, 2025 | $8.86M | $9.72M | -8.84 % |